AiCure

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights. The platform is tailored for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health, providing solutions for biomarker discovery, drug repurposing, lead identification, and treatment response assessment.

Glass is an AI-powered clinical decision support platform that empowers clinicians by providing differential diagnoses and drafting clinical plans. By combining a large language model with evidence-based clinical guidelines, Glass analyzes patient summaries to suggest diagnoses and treatment steps. The platform aims to optimize the practice of medicine, improve patient care, increase diagnostic accuracy, and enhance medical education.

Unlearn.ai is an AI-powered digital twins solution provider that optimizes clinical trials. Their TwinRCTs enable confident and quick clinical trials in various medical fields such as neuroscience, immunology, metabolic disease, and more. By utilizing digital twins, Unlearn.ai aims to revolutionize the traditional clinical trial process by reducing the time to enrollment, improving decision-making in early-stage studies, and attracting study participants. Their innovative approach combines artificial intelligence with patient-level data to enhance the efficiency and effectiveness of clinical research.

ClosedLoop is a healthcare data science platform that helps organizations improve outcomes and reduce unnecessary costs with accurate, explainable, and actionable predictions of individual-level health risks. The platform provides a comprehensive library of easily modifiable templates for healthcare-specific predictive models, machine learning (ML) features, queries, and data transformation, which accelerates time to value. ClosedLoop's AI/ML platform is designed exclusively for the data science needs of modern healthcare organizations and helps deliver measurable clinical and financial impact.

Viz.ai is a leading provider of AI-powered care coordination solutions for healthcare providers. Its comprehensive platform leverages advanced algorithms to analyze medical imaging data, providing real-time insights and automated assessments to accelerate diagnosis and treatment. Viz.ai's solutions cover a wide range of therapeutic areas, including neurology, cardiology, vascular medicine, trauma, and radiology. The company's mission is to improve patient outcomes by closing the gaps between patients, clinicians, and life-saving treatments.

Medical Chat is an advanced AI assistant designed for healthcare professionals, providing instant and accurate medical answers for both human and veterinary medicine. Its capabilities include diagnosing medical conditions, generating differential diagnosis reports, creating patient-specific clinic plans, and offering comprehensive drug information. Medical Chat utilizes the latest LLM models, including ChatGPT 3.5 and 4.0, to deliver reliable and up-to-date medical knowledge. The platform also features a vast database of professional medical textbooks, veterinary books, and PubMed articles, ensuring evidence-based responses. With its HIPAA compliance and commitment to data privacy, Medical Chat empowers healthcare providers to enhance their diagnostic capabilities and improve patient outcomes.

PMcardio is an AI-powered platform that offers accurate and rapid diagnosis of cardiovascular diseases through ECG interpretation. It provides healthcare professionals with the ability to diagnose various cardiac conditions within seconds, ensuring timely referrals and streamlined workflows. PMcardio leverages AI technology to digitize ECG records, enhance clinical decision-making, and standardize ECG reports, ultimately improving the quality of patient care. The platform is designed to cater to both organizations and individuals, offering a range of features and benefits to revolutionize the field of cardiology.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Abridge is a generative AI application designed for clinical conversations in the healthcare industry. It transforms patient-clinician conversations into structured clinical notes in real-time, integrating directly inside Epic. Abridge saves hours of time-consuming documentation per clinician every month, provides clinically accurate summaries across specialties in multiple languages, and creates highly accurate structured clinical note drafts. The application aims to reduce burnout, return time to healthcare teams, bring clarity to patients, and improve efficiencies in healthcare systems.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Consensus is a healthcare interoperability platform that simplifies data exchange and document processing through artificial intelligence technologies. It offers solutions for clinical documentation, HIPAA compliance, natural language processing, and robotic process automation. Consensus enables secure and efficient data exchange among healthcare providers, insurers, and other stakeholders, improving care coordination and operational efficiency.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Beacon Biosignals provides an EEG neurobiomarker platform that is designed to accelerate clinical trials and enable new treatments for patients with neurological and psychiatric diseases. Their platform is powered by machine learning and a world-class clinico-EEG database, which allows them to analyze existing EEG data for insights into mechanisms, PK/PD, and patient stratification. This information can be used to guide further development efforts, optimize clinical trials, and enhance understanding of treatment efficacy.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, techniques. The company's proprietary AI platform is used to identify, re-innovate, and develop potential new therapies. BioXcel Therapeutics has a pipeline of product candidates in various stages of development, including BXCL501 for agitation in dementia, BXCL701 for cocaine use disorder, and BXCL801 for acute suicidal ideation and behavior in patients with major depressive disorder.

Intelligencia AI is a leading provider of AI-powered solutions for the pharmaceutical industry. Our suite of solutions helps de-risk and enhance clinical development and decision-making. We use a combination of data, AI, and machine learning to provide insights into the probability of success for drugs across multiple therapeutic areas. Our solutions are used by many of the top global pharmaceutical companies to improve their R&D productivity and make more informed decisions.

SOMA is a Research Automation Platform that accelerates medical innovation by providing up to 100x speedup through process automation. The platform analyzes medical research articles, extracts important concepts, and identifies causal and associative relationships between them. It organizes this information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like concept analysis, drug repurposing, and target discovery. SOMA enhances literature review efficiency by finding relevant articles based on causal chains and keywords specified by the user. It empowers researchers to focus on their research by saving up to 95% of the time spent on pre-processing documents. The platform offers freemium access with extended functionality for 14 days and advanced features available through subscription.

Unlearn.ai is an AI-powered digital twins solution provider that optimizes clinical trials. Their TwinRCTs enable confident and quick clinical trials in various medical fields such as neuroscience, immunology, metabolic disease, and more. By utilizing digital twins, Unlearn.ai aims to revolutionize the traditional clinical trial process by reducing the time to enrollment, improving decision-making in early-stage studies, and attracting study participants. Their innovative approach combines artificial intelligence with patient-level data to enhance the efficiency and effectiveness of clinical research.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights. The platform is tailored for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health, providing solutions for biomarker discovery, drug repurposing, lead identification, and treatment response assessment.

MediSearch is an AI-powered search engine that provides direct science-based answers to medical questions. Users can ask common health-related questions and dive deeper into complex medical inquiries. The platform aims to offer accurate and reliable information to help individuals make informed decisions about their health. MediSearch is designed to assist users in finding relevant medical information quickly and efficiently.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It helps doctors improve the accuracy of MRI diagnosis, enabling the identification of individuals likely to develop Alzheimer's years in advance. The platform is fully customizable, user-friendly, and can be used by individual doctors and big hospitals. By predicting the likelihood of developing Alzheimer's, NeuProScan optimizes the use of costly PET scans, benefiting patients and healthcare systems.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

Formula Wizard is an AI software designed to automate the process of writing Excel, Notion, and Airtable formulas. By leveraging artificial intelligence, users can save time and unlock insights from their data without the need for manual formula creation. The application simplifies the formula-writing process, allowing users to focus on their work while the AI handles the heavy lifting. With features such as automating tedious tasks, customizing templates, and running advanced calculations, Formula Wizard streamlines data analysis and enhances productivity.

Medallia is an AI-powered text analytics software that enables users to uncover high-impact insights and drive actions with real-time, human-centric text analytics. It offers comprehensive feedback capture, role-based reporting, AI & analytics, integrations, and enterprise-grade security. The platform helps organizations analyze unstructured data, derive hidden meanings behind words, create customizable KPIs, and build out-of-the-box topic models for various industries and use cases.

Luminal is a powerful AI copilot that helps users clean, transform, and analyze spreadsheets 10x faster. It offers fast and efficient data analysis capabilities, enabling users to perform complex operations and run AI-enabled tasks using natural language. With Luminal, users can visualize data, ask complex questions, and clean and format spreadsheets effortlessly. The application supports multiple languages, provides secure data hosting with encryption, and offers simple pricing that scales with user needs.

75 Wbet Com Daftar : OLX500 is an online platform offering a variety of casino games, including slots, live casino, poker, and more. Users can access popular games like Sweet Bonanza, Mahjong Ways, and Gates of Olympus. The platform also provides guidance on how to install the app on Android devices. With a focus on responsible gambling, 75 Wbet Com Daftar : OLX500 aims to enhance the gaming experience for its users.

NexusGPT is an AI tool that allows users to build and integrate custom AI agents to automate workflows without the need for coding. The platform offers a marketplace of tools and integrations, ready-made agents, and the ability to connect with various apps. Users can create autonomous agents that can complete complex tasks by planning and executing. NexusGPT aims to make agent creation, tailoring, and deployment as easy as possible, empowering users to enhance their agent's capabilities with a wide range of tools and AI models.